Matthew B. Stanbrook

3.3k total citations
69 papers, 1.2k citations indexed

About

Matthew B. Stanbrook is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Matthew B. Stanbrook has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pulmonary and Respiratory Medicine, 29 papers in Physiology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Matthew B. Stanbrook's work include Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers), Asthma and respiratory diseases (19 papers) and Respiratory Support and Mechanisms (11 papers). Matthew B. Stanbrook is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (32 papers), Asthma and respiratory diseases (19 papers) and Respiratory Support and Mechanisms (11 papers). Matthew B. Stanbrook collaborates with scholars based in Canada, United Kingdom and United States. Matthew B. Stanbrook's co-authors include Andrea S. Gershon, Teresa To, Nicholas T. Vozoris, Ruth Croxford, Ross Upshur, Thérèse A. Stukel, Peter C. Austin, David N. Juurlink, Kenneth R. Chapman and Andrea Manca and has published in prestigious journals such as JAMA, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Matthew B. Stanbrook

60 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew B. Stanbrook Canada 20 748 501 128 109 96 69 1.2k
Victor A. Kiri United Kingdom 19 822 1.1× 466 0.9× 125 1.0× 70 0.6× 57 0.6× 39 1.4k
Julia F. Slejko United States 15 268 0.4× 313 0.6× 101 0.8× 92 0.8× 269 2.8× 68 1.0k
Kathryn Rice United States 21 1.2k 1.6× 597 1.2× 311 2.4× 73 0.7× 40 0.4× 50 1.7k
Daryl Freeman United Kingdom 17 1.2k 1.6× 786 1.6× 81 0.6× 97 0.9× 39 0.4× 39 1.4k
Trent McLaughlin United States 17 231 0.3× 273 0.5× 92 0.7× 114 1.0× 181 1.9× 50 994
Mathew Williams New Zealand 17 1.4k 1.8× 1.2k 2.5× 58 0.5× 60 0.6× 47 0.5× 35 1.7k
Elisabeth Ståhl Sweden 18 1.3k 1.8× 1.1k 2.2× 96 0.8× 79 0.7× 88 0.9× 28 1.8k
Ruggero M. Corso Italy 15 327 0.4× 296 0.6× 44 0.3× 83 0.8× 56 0.6× 48 891
Tursynbek Nurmagambetov United States 10 504 0.7× 833 1.7× 91 0.7× 82 0.8× 129 1.3× 17 1.4k
S Hummel United Kingdom 11 191 0.3× 514 1.0× 91 0.7× 81 0.7× 467 4.9× 14 1.4k

Countries citing papers authored by Matthew B. Stanbrook

Since Specialization
Citations

This map shows the geographic impact of Matthew B. Stanbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Stanbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Stanbrook more than expected).

Fields of papers citing papers by Matthew B. Stanbrook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew B. Stanbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Stanbrook. The network helps show where Matthew B. Stanbrook may publish in the future.

Co-authorship network of co-authors of Matthew B. Stanbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Stanbrook. A scholar is included among the top collaborators of Matthew B. Stanbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Stanbrook. Matthew B. Stanbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krahn, Murray, Fangyun Wu, Matthew B. Stanbrook, et al.. (2025). Understanding the Growing Burden of Malignant Pleural Effusion – Epidemiology, Healthcare Utilization, and Cost: A Canadian Perspective. Respiration. 104(6). 421–433. 1 indexed citations
2.
Pitre, Tyler, Shao J. Zhou, Susan Kirsh, et al.. (2025). Comparative Effectiveness of Electronic Cigarettes and Pharmacotherapy for Smoking Cessation: A Systematic Review and Bayesian Network Meta-analysis of Randomized Trials. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A7067–A7067.
3.
Pitre, Tyler, et al.. (2025). Biologic Therapies for Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. COPD Journal of Chronic Obstructive Pulmonary Disease. 22(1). 2449889–2449889. 4 indexed citations
4.
Krahn, Murray, et al.. (2024). INCREMENTAL HEALTH CARE UTILIZATION AND COST OF MALIGNANT PLEURAL EFFUSION. CHEST Journal. 166(4). A3650–A3651.
5.
Chaiton, Michael, Susan J. Bondy, Joanna E Cohen, et al.. (2023). Smoking, e-cigarettes and the effect on respiratory symptomsamong a population sample of youth: Retrospective cohortstudy. Tobacco Induced Diseases. 21(January). 1–9. 10 indexed citations
6.
Poon, Michael, Priscila Pequeno, Shawn D. Aaron, et al.. (2022). Trends in non-receipt of recommended COPD medication. ERJ Open Research. 8(2). 584–2021. 2 indexed citations
7.
Jiang, Lili, Tetyana Kendzerska, Shawn D. Aaron, et al.. (2022). Prescription Pathways from Initial Medication Use to Triple Therapy in Older COPD Patients: A Real-World Population Study. COPD Journal of Chronic Obstructive Pulmonary Disease. 19(1). 315–323. 4 indexed citations
8.
Fidler, Lee, Andrea S. Gershon, Jolene H. Fisher, et al.. (2021). Hospitalizations in Sarcoidosis: A Cohort Study of a Universal Healthcare Population. Annals of the American Thoracic Society. 18(11). 1786–1794. 6 indexed citations
9.
Wu, Robert, et al.. (2021). Exogenous lipoid pneumonia associated with oil-based oral and nasal products. Canadian Medical Association Journal. 193(40). E1568–E1571. 1 indexed citations
10.
Kendzerska, Tetyana, Shawn D. Aaron, Teresa To, et al.. (2019). Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma. A Population Study. Annals of the American Thoracic Society. 16(10). 1252–1262. 23 indexed citations
11.
Fidler, Lee, Meyer Balter, Jolene H. Fisher, et al.. (2019). Epidemiology and health outcomes of sarcoidosis in a universal healthcare population: a cohort study. European Respiratory Journal. 54(4). 1900444–1900444. 41 indexed citations
12.
Gershon, Andrea S., Laura C. Maclagan, Jin Luo, et al.. (2018). End-of-Life Strategies among Patients with Advanced Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 198(11). 1389–1396. 26 indexed citations
13.
To, Teresa, Jun Guan, Jingqin Zhu, et al.. (2015). Quality of asthma care under different primary care models in Canada: a population-based study. BMC Family Practice. 16(1). 19–19. 20 indexed citations
14.
Rosenfield, Daniel, et al.. (2011). Il est temps de lutter contre l?abus des stimulants sur nos campus.. Canadian Medical Association Journal. 183(12). 1388–1389. 1 indexed citations
15.
To, Teresa, Astrid Guttmann, M. Diane Lougheed, et al.. (2010). Evidence-based performance indicators of primary care for asthma: a modified RAND Appropriateness Method. International Journal for Quality in Health Care. 22(6). 476–485. 46 indexed citations
16.
Kaplan, Alan & Matthew B. Stanbrook. (2010). Les médecins de famille doivent-ils utiliser la spirométrie dans la prise en charge des patients asthmatiques?: OUI. Canadian Family Physician. 56(2). 130–132. 2 indexed citations
17.
Vozoris, Nicholas T. & Matthew B. Stanbrook. (2010). Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respiratory Medicine. 105(3). 477–484. 75 indexed citations
18.
Austin, Peter C., Andrea Manca, Merrick Zwarenstein, David N. Juurlink, & Matthew B. Stanbrook. (2009). A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. Journal of Clinical Epidemiology. 63(2). 142–153. 119 indexed citations
19.
Attaran, Amir, et al.. (2008). Corrections. Canadian Medical Association Journal. 179(1). 56–56. 1 indexed citations
20.
Stanbrook, Matthew B., K. Flegel, B. Sibbald, et al.. (2007). Congratulations to our colleagues at Open Medicine. Canadian Medical Association Journal. 177(1). 59–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victor A. Kiri Breakdown of academic impact, for papers by Julia F. Slejko Breakdown of academic impact, for papers by Kathryn Rice Breakdown of academic impact, for papers by Daryl Freeman Breakdown of academic impact, for papers by Trent McLaughlin Breakdown of academic impact, for papers by Mathew Williams Breakdown of academic impact, for papers by Elisabeth Ståhl Breakdown of academic impact, for papers by Ruggero M. Corso Breakdown of academic impact, for papers by Tursynbek Nurmagambetov Breakdown of academic impact, for papers by S Hummel
Rankless by CCL
2026